MORSE Team

Posted by MORSE Team

11 MIN READ

CADTH Pharmaceutical Reviews Update – July 2019

August 16, 2019

Posted by MORSE Team

pCPA Closing More Negotiations Without Agreements

August 6, 2019

Posted by MORSE Team

Number of Active Negotiations (49) at Highest Level Since November 2018

July 7, 2019

Posted by MORSE Team

The pCPA Initiates Negotiations for a Second “Group” of Oncology Biosimilars

June 18, 2019

Posted by MORSE Team

April 2019 pCPA Update: The pCPA has completed over 250 negotiations

May 14, 2019

Posted by MORSE Team

March 2019 pCPA Update: Two negotiations initiated prior to completion of CADTH process

April 8, 2019

Posted by MORSE Team

pCPA Trends and Insights – Two Biosimilars Initiated Negotiations and Two Multi-Indication Negotiations were Completed

March 15, 2019

Posted by MORSE Team

MORSE Consulting Releases its 2018 pCPA Year in Review Infographic

March 7, 2019

Posted by MORSE Team

Summary of PMPRB Webinar on Meds Entry Watch, 2017

February 27, 2019

Posted by MORSE Team

A Healthcare-focused Analysis of British Columbia’s 2019 Budget

February 22, 2019

Posted by MORSE Team

pCPA Negotiation Status Update January 2019 – Two Oncology Negotiations Closed without LOI

February 14, 2019

Posted by MORSE Team

Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing Analysis

January 24, 2019

Posted by MORSE Team

pCPA Process Timelines Highlights – A Year-in-Review Primer

January 15, 2019

Posted by MORSE Team

Season’s Greetings from MORSE Consulting

December 20, 2018

Posted by MORSE Team

pCPA Complete its Most Active Month by Adjudicating 15 Files in November

December 20, 2018

Posted by MORSE Team

International Experience with Pharmaceutical Managed Entry Agreements

December 13, 2018

Posted by MORSE Team

BC Pharmacare Now Transitioning Patients on Copaxone® to GLATECT™

November 29, 2018

Posted by MORSE Team

Number of Active pCPA Negotiations at an All-Time High and Continues to Climb

November 19, 2018

Posted by MORSE Team

Significant Developments in Canadian Drugs for Rare Disease Policy

November 14, 2018

Posted by MORSE Team

6 MIN READ

Presidents’ Roundtable – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

November 8, 2018

Posted by MORSE Team

13 MIN READ

Summary of the CADTH Drug Portfolio Information Session Nov. 2018

November 7, 2018

Posted by MORSE Team

12 MIN READ

Patient Support Programs – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

November 1, 2018

Posted by MORSE Team

9 MIN READ

pCPA Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 25, 2018

Posted by MORSE Team

HTA Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 18, 2018

Posted by MORSE Team

8 MIN READ

Summary of the HC-HTA Alignment Webinar Sept. 2018

October 17, 2018

Posted by MORSE Team

PE Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 11, 2018

Posted by MORSE Team

11 MIN READ

pCPA Reducing Time to Initiate Negotiations

October 10, 2018

Posted by MORSE Team

6 MIN READ

Anita Gadhok Strengthens MORSE Consulting’s Payer Expertise

October 9, 2018

Posted by MORSE Team

PMPRB Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 2, 2018

Posted by MORSE Team

12 MIN READ

Summary of pCPA’s Webinar on Biologics Policy Directions & pCPA Negotiations

September 27, 2018

Posted by MORSE Team

Summary of PMPRB Webinar on Compass Rx, 4th Edition 2016/2017

September 21, 2018

Posted by MORSE Team

pCPA Monthly Trends & Insights – August 31, 2018

September 14, 2018

Posted by MORSE Team

CADTH & INESSS Pilot Project: Joint Engagement with Clinical Specialists

September 14, 2018

Posted by MORSE Team

pCPA Monthly Trends & Insights – July 31, 2018

August 13, 2018

Posted by MORSE Team

pCPA Monthly Trends & Insights – June 30, 2018

July 17, 2018

Posted by MORSE Team

pCPA Brand Process Guidelines Webinar

July 3, 2018

Posted by MORSE Team

pCPA Monthly Trends & Insights – May 31, 2018

June 15, 2018

Posted by MORSE Team

pCPA Monthly Trends & Insights – April 2018

May 7, 2018

Posted by MORSE Team

pCPA Update as of March 31, 2018

April 12, 2018

Posted by MORSE Team

MORSE Consulting Proudly Participates at the 2018 CADTH Symposium

April 12, 2018

Posted by MORSE Team

pCPA Monthly Trends & Insights – February 2018

March 13, 2018

Posted by MORSE Team

A Comparison of Proposed INESSS and Current CADTH Evaluation Fees

March 6, 2018

Posted by MORSE Team

pCPA Monthly Trends & Insights – January 2018

February 12, 2018

Posted by MORSE Team

Cornerstone Research Group and MORSE Consulting form a Strategic Partnership

February 7, 2018

Posted by MORSE Team

pCPA: 2017 Year in Review

January 31, 2018

Posted by MORSE Team

pCPA Update as of December 31, 2017

January 16, 2018

Posted by MORSE Team

Brad Alyward Joins MORSE Consulting as Principal Consultant

January 8, 2018

Posted by MORSE Team

Happy Holidays from MORSE Consulting

December 21, 2017

Posted by MORSE Team

pCPA Update as of November 30, 2017

December 8, 2017

Posted by MORSE Team

pCPA Update as of October 31, 2017

November 8, 2017

Posted by MORSE Team

Lorraine Boyle Joins MORSE Consulting as Senior Advisor

October 16, 2017

Posted by MORSE Team

pCPA Update as of September 30, 2017

October 7, 2017

Posted by MORSE Team

Introducing MORSE LINKS – A Comprehensive List of Pharmaceutical Market Access Resources

September 26, 2017

Posted by MORSE Team

pCPA Update as of August 31, 2017

September 11, 2017

Posted by MORSE Team

MORSE Consulting Welcomes WestPAR as a New Strategic Partner

September 11, 2017

Posted by MORSE Team

Upcoming Market Access Events / Conferences – September 2017

August 30, 2017

Posted by MORSE Team

pCPA Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 17, 2017

Posted by MORSE Team

Quebec Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 15, 2017

Posted by MORSE Team

8 MIN READ

Health Technology Assessment Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 10, 2017

Posted by MORSE Team

pCPA Update as of July 31, 2017

August 9, 2017

Posted by MORSE Team

Biosimilar Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 8, 2017

Posted by MORSE Team

pCPA Update as of June 30, 2017

July 10, 2017

Posted by MORSE Team

MORSE Consulting Welcomes a New Strategic Partner

July 5, 2017

Posted by MORSE Team

Upcoming Market Access Events / Conferences – July 2017

June 29, 2017

Posted by MORSE Team

PMPRB Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

June 27, 2017

Posted by MORSE Team

7 MIN READ

Introducing the MORSE WIRE – Live market access news and trends at your finger tips

June 22, 2017

Posted by MORSE Team

Changes in the Private Payer Environment: Great-West Life SMART drug plan

June 20, 2017

Posted by MORSE Team

pCPA Update as of May 31, 2017

June 14, 2017

Posted by MORSE Team

Changes & Updates to CDR Guidelines June 9, 2017

June 12, 2017

Posted by MORSE Team

New Drug Submission Guidelines in Quebec

June 8, 2017

Posted by MORSE Team

Upcoming Market Access Events / Conferences – June 2017

May 23, 2017

Posted by MORSE Team

Federal Health Minister, Hon. Jane Philpott, Announces PMPRB Consultations

May 16, 2017

Posted by MORSE Team

pCPA Update as of April 30, 2017

May 12, 2017

Posted by MORSE Team

MORSE Consulting Welcomes a Strategic Partner and a New Team Member!

May 1, 2017

Posted by MORSE Team

Release of the ODB Program’s 2015/16 Annual Report Card

April 28, 2017

Posted by MORSE Team

Upcoming Market Access Events / Conferences – May 2017

April 26, 2017

Posted by MORSE Team

ODB Formulary Update – April 2017

April 21, 2017

Posted by MORSE Team

Bridging the Gap Between Market Access and Internal Stakeholders [Infographic]

April 19, 2017

Publications, What's New

Posted by MORSE Team

pCPA Update as of March 31, 2017

April 12, 2017

Posted by MORSE Team

Introducing the MORSE KEY – a New Reimbursement Events Calendar

April 12, 2017

Posted by MORSE Team

Market Access Advisory Board Meetings: Bridging the Gap Between Market Access and Internal Stakeholders

April 4, 2017

Posted by MORSE Team

pCPA Update as of February 28, 2017

March 16, 2017

Posted by MORSE Team

Health Canada Guidance Document on the Disclosure of Confidential Business Information – March 10, 2017

March 10, 2017

Posted by MORSE Team

The pan-Canadian Cancer Drug Funding Sustainability Initiative

March 8, 2017

Posted by MORSE Team

Canada Attempts Biosimilar Balancing Act

March 2, 2017

Posted by MORSE Team

Terms of Reference for Scientific Advisory Panel on Opioid Use and Contraindications

February 28, 2017

Posted by MORSE Team

BC Pharmacare Newsletter- February 2017

February 28, 2017

Posted by MORSE Team

Perspective on the pCPA Hepatitis C Negotiation

February 24, 2017

Posted by MORSE Team

Alberta Drug Benefit List – March 2017

February 24, 2017

Posted by MORSE Team

ODB Formulary Update – February 2017

February 24, 2017

Posted by MORSE Team

The February 2017 Update for Quebec’s List of Medications

February 14, 2017

Posted by MORSE Team

PMPRB Releases its February 2017 Newsletter

February 13, 2017

Posted by MORSE Team

pCPA Update as of January 31, 2017

February 9, 2017

Posted by MORSE Team

MORSE Perspective on pCPA Update as of December 31 2016

February 3, 2017

Posted by MORSE Team

New Consultancy Aims to “Decipher” Pharmaceutical Market Access

January 26, 2017

Posted by MORSE Team